(Q73348009)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Y H Gong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A S Parsadanian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Andreeva

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

W D Snider

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J L Elliott

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

660-665

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

3 November 2019

cites work

1 reference

12 December 2020

Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients

1 reference

12 December 2020

BAX is required for neuronal death after trophic factor deprivation and during development

1 reference

12 December 2020

Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate

1 reference

12 December 2020

Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions

1 reference

12 December 2020

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

12 December 2020

Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis

1 reference

12 December 2020

Aberrant RNA splicing in sporadic amyotrophic lateral sclerosis

1 reference

12 December 2020

Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis

1 reference

12 December 2020

Transgenic mice for interleukin 3 develop motor neuron degeneration associated with autoimmune reaction against spinal cord motor neurons

1 reference

12 December 2020

Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite

1 reference

12 December 2020

Localization of neuronal and glial glutamate transporters

1 reference

12 December 2020

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

1 reference

12 December 2020

Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis

1 reference

12 December 2020

Demonstration of poly-N-acetyl lactosamine residues in ameboid and ramified microglial cells in rat brain by tomato lectin binding

1 reference

12 December 2020

SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter.

1 reference

12 December 2020

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

1 reference

12 December 2020

Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation.

1 reference

12 December 2020

Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie

1 reference

12 December 2020

GFAP promoter directs astrocyte-specific expression in transgenic mice.

1 reference

12 December 2020

Glutamate uptake is decreased tardively in the spinal cord of FALS mice.

1 reference

12 December 2020

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

1 reference

12 December 2020

Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons.

1 reference

12 December 2020

Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury

1 reference

12 December 2020

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

1 reference

12 December 2020

Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis

1 reference

12 December 2020

Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis.

1 reference

12 December 2020

Neuronal regulation of glutamate transporter subtype expression in astrocytes.

1 reference

12 December 2020

ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

1 reference

12 December 2020

10.1523/JNEUROSCI.20-02-00660.2000

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10632595%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference